MedCity News
OCTOBER 25, 2022
Through apps, pharmaceutical companies can actually influence patient adherence and mindset after that patient has been prescribed that company’s medication by their physician.
Medgadget
OCTOBER 25, 2022
Scientists at Oregon State University have developed a new treatment for COVID-19. The technology is based on mRNA, which has also been put to good use in COVID-19 vaccines. However, in this instance, the delivered mRNA encodes for human angiotensin-converting enzyme 2 (hACE2), which is the binding site for SARS-CoV-2 on airway cells. The lipid nanoparticle-encapsulated mRNA therapeutic is delivered to cells in the body, and then the cells begin to produce and release a free-floating form of hAC
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 25, 2022
Novartis has abandoned development of its drug to treat presbyopia, a common age-related loss of near distance vision, after it failed a phase 2b trial. The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group’s buyout of privately-held ophthalmology biotech Encore Vision for $375 million upfront in 2017, and was designed to work by restoring the elasticity of the eye’s lens that declines with age.
Medgadget
OCTOBER 25, 2022
Researchers at Osaka University in Japan engineered a wearable electroencephalography (EEG) device that can measure brain activity, potentially letting clinicians monitor conditions such as depression or dementia. At present, assessing brain activity requires a trip to a facility with bulky and expensive equipment, making long-term monitoring difficult.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaVoice
OCTOBER 25, 2022
The company’s co-founder and head of R&D on how it’s using synthetic mRNA to create “smarter” therapies that could provide cures for cancer and more.
Pharmaceutical Technology
OCTOBER 25, 2022
Ast ellas Pharma has announced plans to make a strategic investment to back the development of Taysha Gene Therapies’ adeno-associated virus (AAV) development programmes for Rett syndrome and giant axonal neuropathy (GAN). There are options in the future to possibly apply the worldwide research and development (R&D), manufacturing and marketing expertise of Astellas in gene therapy to AAV gene therapy development programmes of Taysha for genetic ailments of the central nervous system (CNS).
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 25, 2022
BioMed X has entered a research partnership with Sanofi to leverage artificial intelligence (AI) for drug development. Under the joint research project, a new research team will be set up at the BioMed X Institute in Heidelberg, Germany. This team will focus on creating a versatile computational platform that can precisely forecast the first-in-class drug candidates’ efficacy in virtual patient groups.
PM360
OCTOBER 25, 2022
Galen Growth , a leading digital health, data-driven market intelligence company, and FINN Partners , a global integrated marketing services agency, announced a joint effort to mine data and produce the first “Global State of Digital Health Report.” The first report drawing input from some 200M data points and more than 12,000 digital health ventures across the globe, will be released at the November HLTH Conference in Vegas, NV.
pharmaphorum
OCTOBER 25, 2022
AstraZeneca’s IL-5 inhibitor Fasenra is already making blockbuster sales from its use in eosinophilic asthma, but the drugmaker’s efforts to expand its label keep running into difficulties. Earlier this year, the FDA rejected AZ’s application for Fasenra (benralizumab) as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) with a request for more data.
MedCity News
OCTOBER 25, 2022
Banner|Aetna — the Arizona health plan owned by Banner Health and Aetna — rolled out a new frictionless billing program. It is designed to minimize confusion among members by combining billing information from both the provider and payer.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaVoice
OCTOBER 25, 2022
The company's head of U.S. and Canadian operations explains how the company is evolving its game plan after 100 years in the insulin space.
MedCity News
OCTOBER 25, 2022
Many of rural America’s health problems can be traced back to access to care. Rural Americans face environmental and economic access biases that are very different from their urban and suburban counterparts.
MedReps
OCTOBER 25, 2022
When it comes to making sales in the medical equipment and pharmaceutical industry, there are several different techniques. Some salespeople prefer to use social selling or active listening, while others find evidence-based selling works the best. What does evidence-based selling consist of? How can you get started using this method? There are plenty of successful sales reps who swear by it, so learning how to utilize this method can give you the upper hand against the competition.
MedCity News
OCTOBER 25, 2022
Alviss.ai CEO and Founder Dr. Pavel Overtchouk talks about how the company’s stroke prediction software seeks to be the first attempt to apply predictive medicine to cardiovascular interventions and heart surgery.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
pharmaphorum
OCTOBER 25, 2022
Healthware, as the key R&D partner, has been supporting Orion Corporation to design and develop a novel treatment, a Digital Therapeutics software solution “ Rohkea ” to treat Chronic Pain ( DTxP ) using Virtual Reality ( VR ). The efficacy and safety of the product has undergone a clinical trial, and the results were very promising.
MedCity News
OCTOBER 25, 2022
There are five areas that employers need to improve upon to see a rise in their employee retention rates – compensation, benefits, learning & development, culture, and flexibility.
Copyright Clearance Center
OCTOBER 25, 2022
The post Open Access Week 2022: Open Access Resources You Should Know About appeared first on Copyright Clearance Center.
MedCity News
OCTOBER 25, 2022
Astellas has purchased an equity stake in Taysha Gene Therapies in a $50 million deal that gives it an option to license the company’s two lead gene therapy candidates. The Japanese pharmaceutical giant also gains the option to buy its new partner outright depending on clinical and regulatory developments expected in the coming year.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
pharmaphorum
OCTOBER 25, 2022
The time of healthcare professionals is limited, but systems often rely on them as the principal means to help patients with chronic diseases. Ben Hargreaves finds Partha Kar, an advisor to the UK’s NHS, advocating a different approach – one where patients take the lead. Healthcare systems are currently going through a period of reflection on how to serve the needs of the greatest range of patients possible.
MedCity News
OCTOBER 25, 2022
Join us in this webinar presented by flipMD and learn how to remain at the forefront of healthcare and adapt to patients’ needs, business leader, and leverage physician insights.
Medico Reach
OCTOBER 25, 2022
Let’s be honest; most of us are unaware of its meaning or the roles and responsibilities that medical coders perform in the healthcare world. And mind you, what they do is extremely important! Read on to know more about them and a few of the best medical coding companies in USA. What is Medical Coding? The medical coding market in the U.S. was valued at USD 17.9 Billion in 2021.
MedCity News
OCTOBER 25, 2022
Critical applications, medical devices, protected health information (PHI), patient safety, and lives are all at risk when extended downtime occurs. The question is, are you and your team prepared?
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
PharmaTimes
OCTOBER 25, 2022
Millions will be invited to join the programme to ‘prevent, detect and treat’ diseases
MedCity News
OCTOBER 25, 2022
Hospital for Special Surgery spun out a new startup called RightMove Powered by HSS. The company will offer patients virtual triage services and nonsurgical physical therapy. Along with its launch, RightMove announced a $21 million Series A funding round led by Flare Capital and HSS.
PharmaTimes
OCTOBER 25, 2022
A series of virtual hackathons are open for innovators to create a technology-based dementia tool
InCrowd
OCTOBER 25, 2022
In September InCrowd surveyed attending physicians, nurses, medical residents and fellows on their thoughts about Amazon Care. Amazon Care was first launched in 2019 with the hopes of providing 24/7 telehealth services and in-person care to customers in the US. InCrowd collected data on perceptions of Amazon Care from our healthcare audience. While Amazon has since decided to conclude Amazon Care operations on December 31st, the appetite for Amazon’s entry into the healthcare industry rema
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PharmExec
OCTOBER 25, 2022
Wednesday, October 26, 2022 at 2pm EDT|11am PDT|7pm BST|8pm CEST In this webinar, we will we review case studies of successful thought leader engagement plans across the product launch continuum to address the complexity including establishing a modeling framework early, incorporating thought leader behavior profiles and peer recognition data in addition to key milestone for creating the most efficient plan possible.
Legacy MEDSearch
OCTOBER 25, 2022
NeuroOne Medical Technologies Corporation, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Evo sEEG Electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of
Zymewire
OCTOBER 25, 2022
When it comes to cold outreach in the B2B context, one thing is certain: Email is still the dominant channel. Sales professionals at research and manufacturing providers spend hours crafting cold outreach emails to biopharma companies, only to have them go unopened. Why?
Scott Burrows
OCTOBER 25, 2022
What’s New in Safety? (You might not want to know) As a motivational safety speaker, I must admit that I am obsessed with safety. I myself became a safety statistic after leaving a job site. So, keynote speaking on safety isn’t a “lazy exercise” for me.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
125 
Let's personalize your content